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Abstract
Ralstonia species are Gram-negative bacilli that have increasingly been recognized as emerging
nosocomial pathogens, particularly in immunocompromised hosts. Ralstonia pickettii is the
most clinically important pathogen from the Ralstonia genus. Nosocomial outbreaks of
Ralstonia pickettii infections brought about by the use of contaminated medical solutions,
including saline, sterile water, as well as disinfectants, have been reported. There have been
case reports of invasive infections with variable presentations.
Here, we describe three cases of Ralstonia pickettii bacteremia during a period of one year in a
tertiary care hospital in Karachi, Pakistan. The first case was a 76-year-old male, known case of
type 2 diabetes mellitus (DM), hypertension, and amyotrophic lateral sclerosis, who presented
with complaints of burning micturition, hematuria, and fever. The patient had a history of
multiple hospital admissions in the recent past. His blood culture was found to be positive for
Ralstonia pickettii. A computed tomography scan of the kidneys, ureter, and bladder (CT KUB)
was suggestive of pyelonephritis. The patient improved on intravenous meropenem. The
second case was a 47-year-old man, who was admitted with a gunshot injury to the neck,
resulting in complete cervical cord resection and mild hydrocephalus with intraventricular
hemorrhage. The patient had a prolonged intensive care unit (ICU) stay, which was complicated
by ventilator-associated pneumonia with Acinetobacter and central line-associated
bloodstream infection (CLABSI) with Ralstonia pickettii. He was treated with meropenem and
colistin but continued to deteriorate and expired. The third case was a 46-year-old lady, known
case of end-stage renal disease (ESRD), who was admitted with prosthetic valve endocarditis.
She had a prolonged hospital stay complicated by CLABSI with Ralstonia pickettii, improved on
meropenem, but later died due to fungemia. Ralstonia pickettii is an emerging cause of
nosocomial infection in patients, particularly those with a prolonged hospital stay, and can
cause invasive and severe infections.
Categories: Internal Medicine, Infectious Disease
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Introduction
Ralstonia species are Gram-negative bacilli that have increasingly been recognized as emerging
nosocomial pathogens, particularly in immunocompromised hosts [1]. Ralstonia pickettii,
previously known as Burkholderia pickettii, is the most clinically important pathogen from the
Ralstonia genus. Nosocomial outbreaks of Ralstonia pickettii infections brought about by the
use of contaminated medical solutions, including saline, sterile water, as well as disinfectants,
have been reported [2]. There have been case reports of meningitis, infective endocarditis,
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nosocomial pneumonia, and central line-associated bloodstream infection. Most of the
infections occur in immunocompromised, particularly human immunodeficiency virus (HIV),
patients and those with cystic fibrosis. The treatment of Ralstonia infection is still not well-
defined in view of variable sensitivities, particularly to the carbapenems and aminoglycosides
[1]. Here, we describe three cases of Ralstonia pickettii bacteremia, which are the first to be
reported from Pakistan.
Case Presentation
Patient 1
A 76-year-old male, known case of type 2 diabetes mellitus (DM), hypertension, and
amyotrophic lateral sclerosis, presented with complaints of burning micturition, hematuria,
and fever. The patient was found to have increased total leukocyte count (TLC) and acute
kidney injury. The patient had recently been admitted with infected bed sores and treated with
piperacillin-tazobactam for Pseudomonas aeruginosa in pus from the bed sore. He was
suspected with a nosocomial urinary tract infection and started empirically on meropenem.
Urine culture grew Proteus mirabilis, which was pansensitive but the blood culture showed
gram-negative rods, which were later identified to be Ralstonia pickettii that was sensitive to
meropenem so that was continued. A computed tomography scan of the kidneys, ureter, and
bladder (CT KUB) showed bilateral moderate hydronephrosis and hydroureter along with
perinephric fat stranding. The urinary bladder appeared elongated in shape and thick-walled,
along with minimal surrounding fat stranding. The overall findings were suggestive of reflux
nephropathy secondary to bladder outlet obstruction. The patient improved on meropenem
and was treated for 14 days.
Patient 2
A 47-year-old gentleman, with no prior comorbidities, was admitted with a gunshot injury to
the neck, resulting in complete cervical cord resection and mild hydrocephalus with
intraventricular hemorrhage. He was initially managed conservatively. He was noticed to be
developing bilateral pleural effusion, which was heavily septated on the left. He required
intubation and mechanical ventilation. He underwent video-assisted thoracoscopic surgery
(VATS). The pleural fluid culture grew Acinetobacter spp and Pseudomonas aeruginosa. The
patient had a prolonged intensive care unit (ICU) stay, which was complicated by ventilator-
associated pneumonia with Acinetobacter and central-line associated bloodstream infection
(CLABSI) with Ralstonia pickettii. He was treated with meropenem and colistin but had no
meaningful neurological recovery and continued to deteriorate. It was decided by the family to
withdraw support, and he expired.
Patient 3
A 46-year-old lady, known case of hypertension, end-stage renal disease requiring thrice
weekly hemodialysis, and recent history of mitral valve replacement due to culture negative
native valve infective endocarditis was admitted with non-ST elevation myocardial infarction.
She required invasive ventilation and was admitted to the intensive care unit. She developed
central line-associated bloodstream infection with Ralstonia pickettii. She was treated with
intravenous meropenem. However, the patient continued to worsen clinically, as well as in
terms of leukocytosis. Hence, intravenous levofloxacin was added to the treatment regimen.
This led to an improvement in clinical parameters. However, the hospital course was prolonged
and she eventually died of fungemia, again secondary to central line infection. Table 1 shows a
summary of all three cases.
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 Age/Gender
Source of
Infection
Total Leukocyte Count
(x10E9/L) Treatment Outcome
Day 1 Day 3
Patient
1
76/M Pyelonephritis 20 13.8
Intravenous Meropenem &
Colistin
Recovery
Patient
2
47/M CLABSI 11.2 5.7 Intravenous Meropenem Death
Patient
3
46/F CLABSI 33 26
Intravenous Meropenem &
Levofloxacin
Death
TABLE 1: SUMMARY OF CASES
central line-associated bloodstream infection (CLABSI)
Discussion
Ralstonia pickettii is an emerging Gram-negative opportunistic pathogen [1]. It is an aerobic
non-fermenting bacillus, which is found in soil and water. Ralstonia pickettii has been rarely
known to cause severe invasive infections, including pneumonia, endocarditis, osteomyelitis,
meningitis, and septic arthritis [1-3]. It is a waterborne organism of low virulence, with a
propensity to cause severe infections in the immunocompromised, resulting in significant
mortality and morbidity [1]. Among our cases, two of the patients had chronic debilitating
illnesses, which could have weakened their immune systems, predisposing them to infection
with this organism. A number of cases have been attributed to contaminated solutions, e.g.,
saline solutions given as an intravenous infusion or utilized in wound cleaning or for
endotracheal suctioning and reported from the contamination of dialysis water and
extracorporeal membrane oxygenation therapy [4-7]. These have resulted in bloodstream, as
well as respiratory, infections. However, in all of our cases, we could not identify any potential
source of contamination. The underlying conditions reported to have been associated include
alcoholic cirrhosis, diabetes mellitus, and intravenous drug abuse [1,8]. Two of our cases had
hypertension, one had diabetes and end-stage renal disease while one patient had a prolonged
ICU stay, which likely led to a nosocomial acquisition of organism. There have been reports of
central line-associated infections with this pathogen and CLABSI was the identified source of
infection in two of our cases also [9]. There have been several instances of outbreaks and
because of the ubiquitous nature of the organism, differentiating between bacteremia and
pseudo-bacteremia is important to avoid unnecessary treatment [4,10-11]. In vitro data
suggest susceptibility to ceftriaxone but clinical failure has been reported and has been
attributed to a lack of understanding of resistance mechanisms [12]. Other studies have shown
in vitro susceptibility to quinolones, trimethoprim, and sulphamethoxazole [13]. Patients
usually respond to intravenous third and fourth generation cephalosporins, which have been
used as either monotherapy or in combination with amikacin or carbapenems [10]. We had used
meropenem based on the susceptibility of our isolates. Colistin was used as part of the regimen
in one of our cases because of multi-drug resistant (MDR) Acinetobacter pneumonia. One out
of the three cases developed clinical failure with meropenem monotherapy, leading to the
addition of levofloxacin based on culture and susceptibility, which resulted in improvement, as
well as microbiological eradication evidenced by the clearance of blood culture. There have
been reports of failure with meropenem where improvement was achieved with quinolones
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[14]. Treatment outcomes vary depending on the source of infection. Mortality in one of the
series was reported to be around 7% [1]. Two out of three of our cases died, showing a poor
outcome with infections caused by this organism. Our cases are the first to be reported from this
region and highlight the importance of suspecting these infections in patients with healthcare-
associated infections or who have had recent hospitalization or prolonged hospital stay
requiring multiple interventions and invasive catheters. Table 2 summarizes the clinically
significant bloodstream infections caused by Ralstonia pickettii.
Case report
Authors
No of
cases
Source of Infection Treatment Outcome
Tejera D. et al. [6] 2
Contaminated hemodialysis
water
Meropenem, Piperacillin Tazobactam Recovered
Kismet E. et al. [9] 2 CLABSI Meropenem, Cefepime Recovered
Orme J. et al. [2] 1 Infective endocarditis
Trimethoprim-sulfamethoxazole and
levofloxacin
Died
Strateva T. et al.
[15]
1
Contaminated hemodialysis
water
Levofloxacin Recovered
Khajuria A. et al.
[16]
1 Surgical site infection Tigecycline Recovered
TABLE 2: SUMMARY OF CASE REPORTS OF CLINICALLY SIGNIFICANT RALSTONIA
PICKETTII BLOODSTREAM INFECTIONS
central line-associated bloodstream infection (CLABSI)
Conclusions
Ralstonia pickettii should be considered an important pathogen causing hospital-acquired
infections, particularly among patients who are immunocompromised, as it can have a poor
prognosis.
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